Biodesix, Inc.
BDSX
$0.549
-$0.0046-0.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.55% | 1.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.55% | 1.26% | |||
| Cost of Revenue | 3.90% | 7.79% | |||
| Gross Profit | 15.14% | -0.54% | |||
| SG&A Expenses | 1.01% | 1.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.87% | 2.48% | |||
| Operating Income | 23.80% | -5.15% | |||
| Income Before Tax | 19.57% | 5.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.57% | 5.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.57% | 5.09% | |||
| EBIT | 23.80% | -5.15% | |||
| EBITDA | 28.20% | -5.05% | |||
| EPS Basic | 19.69% | 17.53% | |||
| Normalized Basic EPS | 20.78% | 15.12% | |||
| EPS Diluted | 19.69% | 17.53% | |||
| Normalized Diluted EPS | 20.78% | 15.12% | |||
| Average Basic Shares Outstanding | 0.21% | 15.04% | |||
| Average Diluted Shares Outstanding | 0.21% | 15.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||